A PHASE 2 STUDY OF TRASTUZUMAB EMTANSINE IN JAPANESE PATIENTS WITH HER2 POSITIVE METASTATIC BREAST CANCER

被引：0

作者：

Takahashi, S.

Kashiwaba, M. ^{[1
]}

Takao, S. ^{[2
]}

Ito, Y.

Doihara, H. ^{[3
]}

Rai, Y.

Matsubara, M.

Kanatani, K.

Masuda, N. ^{[4
]}

机构：

[1] Iwate Med Univ, Morioka, Iwate, Japan

[2] Hyogo Canc Ctr, Kobe, Hyogo, Japan

[3] Okayama Univ Hosp, Okayama, Japan

[4] NHO Osaka Natl Hosp, Osaka, Japan

来源：

ANNALS OF ONCOLOGY | 2013年 / 24卷

关键词：

D O I：

10.1093/annonc/mdt448

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：20 / 20

页数：1

共 50 条

[21] A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer [J].

Zhao, Meng ;

Pan, Xueliang ;

Layman, Rachel ;

Lustberg, Maryam B. ;

Mrozek, Ewa ;

Macrae, Erin R. ;

Wesolowski, Robert ;

Carothers, Sarah ;

Puhalla, Shannon ;

Shapiro, Charles L. ;

Ramaswamy, Bhuvaneswari .

INVESTIGATIONAL NEW DRUGS, 2014, 32 (06) :1285-1294

[22] Ado-Trastuzumab Emtansine (Kadcyla) for HER2-Positive Metastatic Breast Cancer [J].

不详 .

MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2013, 55 (1425) :73-75

[23] Trastuzumab emtansine in HER2-positive metastatic breast cancer: what is the best sequence? [J].

Ricci, Francesco ;

Le Tourneau, Christophe .

CHINESE CLINICAL ONCOLOGY, 2018, 7 (01)

[24] Changes in the expression of HER2 and other genes in HER2-positive metastatic breast cancer induced by treatment with ado-trastuzumab emtansine and/or pertuzumab/trastuzumab [J].

Kida, K. ;

Lee, J. ;

Liu, H. ;

Lim, B. ;

Murthy, R. K. ;

Sahin, A. A. ;

Tripathy, D. ;

Ueno, N. T. .

CANCER RESEARCH, 2019, 79 (04)

[25] Phase I trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer [J].

Mundi, P. S. ;

Lee, S. ;

Chi, D. ;

Bhardwaj, A. ;

Makower, D. ;

Cigler, T. ;

Crew, K. D. ;

Hershman, D. L. ;

Califano, A. ;

Silva, J. ;

Kalinsky, K. M. .

CANCER RESEARCH, 2017, 77

[26] A Multicenter Phase 2 Study (JO22997) Evaluating the Efficacy and Safety of Trastuzumab Emtansine in Japanese Patients With Heavily Pretreated HER2-Positive Metastatic Breast Cancer [J].

Masuda, N. ;

Ito, Y. ;

Takao, S. ;

Doihara, H. ;

Rai, Y. ;

Horiguchi, J. ;

Kohno, N. ;

Fujiwara, Y. ;

Tokuda, Y. ;

Watanabe, J. ;

Iwata, H. ;

Ishiguro, H. ;

Miyoshi, Y. ;

Matsubara, M. ;

Kashiwaba, M. .

CANCER RESEARCH, 2012, 72

[27] Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer [J].

Verma, Sunil ;

Miles, David ;

Gianni, Luca ;

Krop, Ian E. ;

Welslau, Manfred ;

Baselga, Jose ;

Pegram, Mark ;

Oh, Do-Youn ;

Dieras, Veronique ;

Guardino, Ellie ;

Fang, Liang ;

Lu, Michael W. ;

Olsen, Steven ;

Blackwell, Kim .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (19) :1783-1791

[28] Pertuzumab and trastuzumab-emtansine in HER2 positive metastatic colorectal cancer: the HERACLES B TRIAL [J].

Sartore-Bianchi, A. ;

Marsoni, S. ;

Trusolino, L. ;

Martino, C. ;

Lonardi, S. ;

Leone, F. ;

Cottino, F. ;

Vurchio, V. ;

Valtorta, E. ;

Lauricella, C. ;

Zagonel, V. ;

Racca, P. ;

Ciardiello, F. ;

Ardizzoni, A. ;

Tonini, G. ;

Aglietta, M. ;

Siena, S. .

ANNALS OF ONCOLOGY, 2016, 27

[29] Radiolabeled trastuzumab biodistribution and serum HER2 levels in HER2-positive metastatic breast cancer patients [J].

Perik, Patrick J. ;

Lub-de Hogge, Marjolijn N. ;

Gietema, Jourik A. ;

Jager, Piet L. ;

Kosterink, Jos G. ;

de Korte, Sander A. ;

van Veldhuisen, Drik J. ;

van der Graaf, Winette T. ;

Sieijfer, Drik T. ;

de Vries, Elisabeth G. .

ANNALS OF ONCOLOGY, 2004, 15 :14-14

[30] HER2 Heterogeneity Affects Trastuzumab Responses and Survival in Patients With HER2-Positive Metastatic Breast Cancer [J].

Lee, Hee Jin ;

Seo, An Na ;

Kim, Eun Joo ;

Jang, Min Hye ;

Suh, Koung Jin ;

Ryu, Han Suk ;

Kim, Yu Jung ;

Kim, Jee Hyun ;

Im, Seock-Ah ;

Gong, Gyungyub ;

Jung, Kyung Hae ;

Park, In Ae ;

Park, So Yeon .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 142 (06) :755-766

← 1 2 3 4 5 →